3-[3-(2-Cyanophenylsulfonyloxy)-5-methylphenoxy]propoxyamine → 3-[3-(2-Cyanophenylsulfonyloxy)-5-methylphenoxy]propanol Hydrochloride

HRID 1059462

반응식

HRID 1059462 반응식
[C:1]([C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[S:9]([O:12][C:13]1[CH:14]=[C:15]([CH:22]=[C:23]([CH3:25])[CH:24]=1)[O:16][CH2:17][CH2:18][CH2:19][O:20]N)(=[O:11])=[O:10])#[N:2].[ClH:26].N1C=CC(C(N)=N)=N1>CN(C)C=O>[ClH:26].[C:1]([C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[S:9]([O:12][C:13]1[CH:14]=[C:15]([CH:22]=[C:23]([CH3:25])[CH:24]=1)[O:16][CH2:17][CH2:18][CH2:19][OH:20])(=[O:11])=[O:10])#[N:2]

참가 물질

4

반응물 2

HCID 227225313-[3-(2-Cyanophenylsulfonyloxy)-5-methylphenoxy]propoxyamineHCID 178479321HCID 178479321, 화합물

생성물 1

HCID 186697053-[3-(2-Cyanophenylsulfonyloxy)-5-methylphenoxy]propanol Hydrochloride수율 88.6%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

3-[13-(2-Cyanophenylsulfonyloxy)-5-methylphenoxy]propoxy guanidine hydrochloride: To a solution of 3-[3-(2-cyanophenylsulfonyloxy)-5-methylphenoxy] propoxyamine (362 mg, 1.0 mmol), as prepared in the preceding step, in N,N-dimethylformamide (10 mL) was added 1H-pyrazole-carboxamidine hydrochloride (590 mg, 4.0 mmol). The reaction mixture was stirred at ambient temperature for two days. N,N-Dimethylformamide was removed under high vacuum. Acetonitrile (10 mL) was added, the solid was removed by filtration, the filtrate was concentrated in vacuo, and the residue was dried under high vacuum. The residue was partitioned between water (30 mL plus 2 mL brine) and diethyl ether (20 mL). The water solution was extracted with diethyl ether (20 mL), and the combined diethyl ether extracts were extracted with acidic water (pH 5). The combined water solutions were adjusted to pH 8-9 by using 2N NaOH and extracted with ethyl acetate (3×50 mL). The ethyl acetate solution was washed with pH 7 buffer solution (2×30 mL) and brine (30 mL) and dried over Na2SO4. After removing the solvent. 0.6 N HCl methanol (10 mL) was added, and the solution was concentrated to give the title compound as a colorless oil (340 mg, 77%). 1H-NMR (300 MHz, DMSO-d6) δ 8.30 (d, J=7.5 Hz, 1H), 8.09 (t, J=7.5 Hz, 1H), 8.04 (m, 2H), 7.72 (br s, 5H), 6.79 (s, 1H), 6.49 (s, 1H), 6.47 (s, 1H), 3.99 (t, J=6.2 Hz, 2H), 3.90 (t, J=6.3 Hz, 2H), 2.22 (s, 3H), 2.01 (m, 2H). Mass spectrum (MALDI-TOF, α-cyano-4-hydroxycinnamic acid matrix) calcd. for C18H20N4O5S: 405.1 (M+H), 427.1 (M+Na). Found: 405.1, 427.0.

후처리

  1. customN,N-Dimethylformamide was removed under high vacuum
  2. additionAcetonitrile (10 mL) was added
  3. customthe solid was removed by filtration
  4. concentrationthe filtrate was concentrated in vacuo
  5. customthe residue was dried under high vacuum
  6. customThe residue was partitioned between water (30 mL plus 2 mL brine) and diethyl ether (20 mL)
  7. extractionThe water solution was extracted with diethyl ether (20 mL)
  8. extractionthe combined diethyl ether extracts were extracted with acidic water (pH 5)
  9. extractionextracted with ethyl acetate (3×50 mL)
  10. washThe ethyl acetate solution was washed with pH 7 buffer solution (2×30 mL) and brine (30 mL)
  11. dry with materialdried over Na2SO4
  12. customAfter removing the solvent
  13. addition0.6 N HCl methanol (10 mL) was added
  14. concentrationthe solution was concentrated

출처 및 근거

ORD 기록
ord-6acf45b3ca7645f5aadd10c598a3dacc
출처 데이터셋
uspto-grants-2003_02
특허 번호
US06518310B2

연결된 노트

불러오는 중…